220 related articles for article (PubMed ID: 24618232)
1. Extracellular matrix assessment of infected chronic venous leg ulcers: role of metalloproteinases and inflammatory cytokines.
Serra R; Grande R; Buffone G; Molinari V; Perri P; Perri A; Amato B; Colosimo M; de Franciscis S
Int Wound J; 2016 Feb; 13(1):53-8. PubMed ID: 24618232
[TBL] [Abstract][Full Text] [Related]
2. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
[TBL] [Abstract][Full Text] [Related]
3. Role of matrix metalloproteinases in non-healing venous ulcers.
Amato B; Coretti G; Compagna R; Amato M; Buffone G; Gigliotti D; Grande R; Serra R; de Franciscis S
Int Wound J; 2015 Dec; 12(6):641-5. PubMed ID: 24164799
[TBL] [Abstract][Full Text] [Related]
4. Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin.
Serra R; Buffone G; Falcone D; Molinari V; Scaramuzzino M; Gallelli L; de Franciscis S
Wound Repair Regen; 2013; 21(3):395-401. PubMed ID: 23531093
[TBL] [Abstract][Full Text] [Related]
5. The effects of sulodexide on both clinical and molecular parameters in patients with mixed arterial and venous ulcers of lower limbs.
Serra R; Gallelli L; Conti A; De Caridi G; Massara M; Spinelli F; Buffone G; Caliò FG; Amato B; Ceglia S; Spaziano G; Scaramuzzino L; Ferrarese AG; Grande R; de Franciscis S
Drug Des Devel Ther; 2014; 8():519-27. PubMed ID: 24872682
[TBL] [Abstract][Full Text] [Related]
6. Induction of MMP-1, MMP-3 and TIMP-1 in normal dermal fibroblasts by chronic venous leg ulcer wound fluid*.
Subramaniam K; Pech CM; Stacey MC; Wallace HJ
Int Wound J; 2008 Mar; 5(1):79-86. PubMed ID: 18336381
[TBL] [Abstract][Full Text] [Related]
7. From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases.
Serra R; Gallelli L; Butrico L; Buffone G; Caliò FG; De Caridi G; Massara M; Barbetta A; Amato B; Labonia M; Mimmi S; Iaccino E; de Franciscis S
Int Wound J; 2017 Feb; 14(1):233-240. PubMed ID: 26991748
[TBL] [Abstract][Full Text] [Related]
8. Inflammation in chronic venous ulcers.
Raffetto JD
Phlebology; 2013 Mar; 28 Suppl 1():61-7. PubMed ID: 23482537
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new nutraceutical substance on clinical and molecular parameters in patients with chronic venous ulceration.
Serra R; Grande R; Butrico L; Buffone G; Caliò FG; Squillace A; Rizzo BA; Massara M; Spinelli F; Ferrarese AG; de Caridi G; Gallelli L; de Franciscis S
Int Wound J; 2016 Feb; 13(1):88-96. PubMed ID: 24612734
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors.
Trengove NJ; Stacey MC; MacAuley S; Bennett N; Gibson J; Burslem F; Murphy G; Schultz G
Wound Repair Regen; 1999; 7(6):442-52. PubMed ID: 10633003
[TBL] [Abstract][Full Text] [Related]
11. Doxycycline speeds up healing of chronic venous ulcers.
Serra R; Gallelli L; Buffone G; Molinari V; Stillitano DM; Palmieri C; de Franciscis S
Int Wound J; 2015 Apr; 12(2):179-84. PubMed ID: 23557025
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of extracellular matrix metalloproteinase inducer (CD147) and membrane-type matrix metalloproteinases in venous leg ulcers.
Norgauer J; Hildenbrand T; Idzko M; Panther E; Bandemir E; Hartmann M; Vanscheidt W; Herouy Y
Br J Dermatol; 2002 Dec; 147(6):1180-6. PubMed ID: 12452868
[TBL] [Abstract][Full Text] [Related]
13. Behaviour of the plasma concentration of gelatinases and their tissue inhibitors in subjects with venous leg ulcers.
Caimi G; Ferrara F; Montana M; Muratori I; Amato C; Canino B; Lo Presti R; Hopps E
Clin Hemorheol Microcirc; 2015; 60(3):309-16. PubMed ID: 25159491
[TBL] [Abstract][Full Text] [Related]
14. Cytokine and protease levels in healing and non-healing chronic venous leg ulcers.
Harris IR; Yee KC; Walters CE; Cunliffe WJ; Kearney JN; Wood EJ; Ingham E
Exp Dermatol; 1995 Dec; 4(6):342-9. PubMed ID: 8608341
[TBL] [Abstract][Full Text] [Related]
15. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers.
Ladwig GP; Robson MC; Liu R; Kuhn MA; Muir DF; Schultz GS
Wound Repair Regen; 2002; 10(1):26-37. PubMed ID: 11983004
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers.
Senet P; Bon FX; Benbunan M; Bussel A; Traineau R; Calvo F; Dubertret L; Dosquet C
J Vasc Surg; 2003 Dec; 38(6):1342-8. PubMed ID: 14681639
[TBL] [Abstract][Full Text] [Related]
17. Uncontrolled gelatin degradation in non-healing chronic wounds.
Trøstrup H; Holstein P; Karlsmark T; Moser C; Ågren MS
J Wound Care; 2018 Nov; 27(11):724-734. PubMed ID: 30398935
[TBL] [Abstract][Full Text] [Related]
18. The relationship between cytokine concentrations and wound healing in chronic venous ulceration.
Gohel MS; Windhaber RA; Tarlton JF; Whyman MR; Poskitt KR
J Vasc Surg; 2008 Nov; 48(5):1272-7. PubMed ID: 18771884
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase (MMP)-1 and MMP-2, but not COX-2 serve as additional predictors for chronic venous ulcer healing.
Bergant Suhodolčan A; Luzar B; Kecelj Leskovec N
Wound Repair Regen; 2021 Sep; 29(5):725-731. PubMed ID: 33768649
[TBL] [Abstract][Full Text] [Related]
20. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers.
Nwomeh BC; Liang HX; Cohen IK; Yager DR
J Surg Res; 1999 Feb; 81(2):189-95. PubMed ID: 9927539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
